top of page


Biomarkers of Human Longevity: State of the Market and Diversity of Practical Applications Q4 2021

Longevity Industry 1.0 Guest Author Roundtable


Biomarkers of Human Longevity: State of the Market and Diversity of Practical Applications Q4 2021

Biomarkers of Human Longevity Conference (1920х1080).png
Longevity Industry

Biomarkers of Human Longevity: State of the Market and Diversity of Practical Applications Q4 2021

The Longevity Industry 1.0 Guest Author Roundtable is an exclusive online event exploring in detail some of the guest chapter contributions to “Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History” moderated by Robin Farmanfarmaian, a contributor to the book and bestselling author of The Patient as CEO: How Technology Empowers the Healthcare Consumer, and hosted by Franco Cortese, Director of Aging Analytics Agency. During the event, Robin will hold a roundtable discussion with Longevity Book guest contributors Kate Batz, Sergey Balasanyan and Franco Cortese, centered around their individual chapter contributions, as well as why this book in particular is so important during this current inflection point of the Global Longevity Industry’s continuing growth and diversification, covering topics such as the role of AI in Longevity R&D and practical implementation, the intersection of  Longevity with Preventive Medicine 
and Precision Health, differing region-specific Longevity investment approaches, and the rise of Longevity-focused banks and FinTech companies.

Meet the co-author of "Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History"​

imageonline-co-transparentimage (4).png


Dmitry Kaminskiy is an innovative entrepreneur and investor, active in the fields of Longevity, Precision Medicine, and Artificial Intelligence. He is a co-founder and managing partner at Deep Knowledge Ventures, a leading investment fund focused on DeepTech, renowned for its use of sophisticated analytical systems for investment target identification and due diligence. He is a frequent speaker on AI and Longevity, including events organized in London by The Economist ("Aging Societies and The Business of Longevity") and organized by the Financial Times ("Smart Machines vs. Smart People" and "Global Pharmaceutical and Biotechnology Conference"), as well as the "Precision Medicine World Conference" in Silicon Valley, and other events at Oxford and Cambridge universities. He is actively involved in the work of the initiative group and was instrumental in the initial stage of the launch of the All-Party Parliamentary Group for Longevity in the UK Parliament. He now serves as co-director of the secretariat, overseeing the APPG's international Longevity cooperation development division.

​Meet the guest contributors of "Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History"​



Robin Farmanfarmaian is a professional speaker, entrepreneur, and angel investor, focusing on cutting-edge healthcare and biotech companies poised to impact 100M patients. Currently Farmanfarmaian is the CEO and Co-founder of ArO, dynamic vision correction and eye health monitoring. Recent investments include Invicta Medical, a medical technology company for sleep apnea, & Dance Biopharm, inhaled insulin with a smart, connected device.

With over 125 speaking engagements in 12 countries, Farmanfarmaian educates audiences on technology, the future of healthcare, patient empowerment, building thought leadership, and more. She has 3 published books: “The Patient as CEO: How Technology Empowers the Healthcare Consumer” (2015), "The Thought Leader Formula: Strategically Leverage Your Expertise to Drive Business & Career Goals" (2019) and "Facilitating Virtual Events: Driving Participant Engagement & Interaction" (2020).


Kate Batz is Managing Partner of Longevity.Capital, a specialized investment fund focused on the longevity industry. She is also Director of Strategy and Business Development at Deep Knowledge Ventures Group, comprising of Deep Knowledge Ventures, Aging Analytics Agency, and Deep Knowledge Analytics.  

Kate is an experienced corporate attorney by background, licensed to practice law in California, New York, and Russia, with extensive sales and marketing experience. At the beginning of her career, Kate was involved with international litigation when she worked for a former Pennsylvania state senator. As a corporate attorney, Kate worked with many Fortune 500 clients. Compelled by the paradigm-shifting advances in science and technology in the fields of aging and Longevity, Kate joined Deep Knowledge Ventures Group. Kate is based in San Francisco, California.


Franco Cortese is Director of Aging Analytics Agency, and has been a member of the company’s executive management team since its inception. He is one of the co-creators of the Longevity Industry Framework behind many of the company’s Longevity Industry analytics, benchmarking and forecasting.

He is also one of five co-authors behind the proposal that led to the World Health Organization's addition of a new extension code for aging-related diseases (XT9T) during ICD-11, and the author of over a dozen scientific papers in peer-reviewed journals such as Scientific Reports (Nature Publishing Group), Experimental Gerontology, Aging, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences (Oxford Academic), Sleep (Oxford Academic), Human Gene Therapy, Frontiers in Genetics, Rejuvenation Research, Oncotarget, Translational Neurodegeneration and others.
Learn More about Franco


Sergey Balasanyan is an experienced FinTech and banking professional, and the CEO of Longevity Card. Sergey is also the contributor to Forbes Austria and other magazines, and Guest contributor to “Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History”. In 2020 he was ranked among the Top 15 EU Tech Pioneers with Big Ideas by Sifted, a subsidiary of Financial Times, and as a Longevity Financial Industry Leader by the nonprofit consortium Longevity.International.

Longevity Card began during Sergey’s time as an Entrepreneur in Residence at Deep Knowledge Group, which launched the project in order to unite health and wealth by combining the Group’s significant expertise in Longevity Industry analytics with Sergey’s own personal banking and fintech experience in order to shift the focus of traditional banking toward Longevity and health, and later spinning out the project into its own independent company as Longevity Card.

Event Agenda

13th October 2020

9:00-10:00am PDT / 5:00pm-6:00pm BST / 6:00-7:00pm CET

9:00 - 9:03 - Franco Cortese lets attendees join the Zoom conference

9:03 - 9:10 - Opening Remarks by Franco Cortese

9:10 - 9:17 - Speech and Presentation by Robin Farmanfarmaian

9:17 - 9:24 - Speech and Presentation by Kate Batz

9:24 - 9:27 - Speech and Presentation by Sergey Balasanyan

9:27 - 9:35 - Speech and Presentation by Dmitry Kaminskiy

9:35 - 9:55 - Panel Discussion Moderated by Robin Farmanfarmaian (with Dmitry Kaminskiy, Kate Batz, Sergey Balasanyan & Franco Cortese)

9:55 - 10:00 - Closing Remarks by Franco Cortese

About The Longevity Industry 1.0 Book

In “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History”, seasoned Longevity industry professionals Dmitry Kaminskiy and Margaretta Colangelo distill the complex assembly of deep market intelligence and industry knowledge that they have developed over the past 5 years into a full-scope understanding of the global Longevity Industry, showing the public exactly how they managed to define the overwhelmingly complex and multidimensional Longevity Industry for the first time, and how they created a tangible framework for its systematization and forecasting.


Previous Events

Longevity Industry 1.0  Book Launch

bottom of page